Walker Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$805K Buy
671
+1
+0.1% +$1.02K 0.41% 53
2026
Q1
$617K Buy
670
+12
+2% +$12.2K 0.33% 59
2025
Q4
$707K Buy
658
+1
+0.2% +$956 0.38% 48
2025
Q3
$502K Sell
657
-8
-1% -$5.95K 0.28% 67
2025
Q2
$519K Buy
665
+1
+0.2% +$777 0.3% 57
2025
Q1
$548K Sell
664
-29
-4% -$24.1K 0.33% 49
2024
Q4
$535K Buy
693
+10
+1% +$8.28K 0.33% 51
2024
Q3
$605K Buy
683
+29
+4% +$26.1K 0.38% 42
2024
Q2
$592K Sell
654
-49
-7% -$39.2K 0.4% 41
2024
Q1
$547K Sell
703
-61
-8% -$43.4K 0.36% 45
2023
Q4
$445K Buy
+764
New +$446K 0.32% 52

Other funds holding LLY

Walker Asset Management's LLY Position: Q2 2026 in Review

Walker Asset Management increased its Eli Lilly (LLY) stake by 0.15% in Q2 2026, buying an estimated $1.02K and bringing the position to 671 shares worth $805K. The position accounts for 0.41% of the portfolio, ranked #53.

Walker Asset Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Walker Asset Management held 671 shares of Eli Lilly worth $805K as of Q2 2026.
  • Walker Asset Management bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.41% of Walker Asset Management's portfolio in Q2 2026, its #53 holding.
  • Walker Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Walker Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.